Associate Professor, Neurosurgery, Perelman School of Medicine
Neurosurgery
Paul Marcotte practices Neurosurgery. He over the years received 5 awards: "CMS Meaningful Use Stage 1 Certification", "Top MD", "Whos Who in Medicine and Healthcare", "Fellow (FACS)" and "Fellow (FAANS)". Paul Marcotte is a published doctor and has 19 publications published. The lastest was: 'Dural arteriovenous fistulas involving the superior sagittal sinus: acute presentation with intracranial hemorrhage.' Dr. Paul J. Marcotte accepts all Medicare patients.
Publications
Schools
University Of Ottawa Faculty Of Medicine
Ottawa Civil Hospital
Ottawa Civil and Genl Hospital University Ottawa
Barrow Neur Institute St Josephs Hospital
Procedures Preformed
- CerebroSpinal Fluid (CSF) Shunt - Insertion, Repair or Removal
- Craniectomy, Craniotomy, Surgery of Skull Base, Neuroendoscopy
- Dural Repair or Other Spinal Spinal Cord Repair
- Herniated Disc Surgery
- View All
Conditions Treated
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Aneurysm
- Brain Cancer
- Cerebral Artery Thrombosis
- View All
Doctors Specialties
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Top MD
- Whos Who in Medicine and Healthcare
- Fellow (FACS)
- Fellow (FAANS)
Education
-
Barrow Neurological Institute
-
University of Ottawa Faculty of Medicine
Hospital
-
Hospital of the University of Pennsylvania
-
Pennsylvania Hospital
Drug Facts
NPI NUMBER |
|
1124064795 |
NPPES Provider LastName |
|
MARCOTTE |
NPPES Provider FirstName |
|
PAUL |
NPPES Provider ZIPCode |
|
19104 |
NPPES Provider State |
|
PA |
Specialty Description |
|
Neurosurgery |
Total Claim Count |
|
90.0 |
Distinct Opioid Count |
|
1.0 |
Opioid Claim Count |
|
16.0 |
Percent Opioid Claims |
|
17.78 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1124064795 |
Last Name Of The Provider |
MARCOTTE |
First Name Of The Provider |
PAUL |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog